Clovis Oncology, Inc. Annual Operating Income (Loss) in USD from 2010 to 2021

Taxonomy & unit: us-gaap: USD
Description: The net result for the period of deducting operating expenses from operating revenues.
Summary: Clovis Oncology, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2021.
Clovis Oncology, Inc. Operating Income (Loss) for the quarter ending September 30, 2022 was -$44.2M, a 23% increase year-over-year.
Clovis Oncology, Inc. Operating Income (Loss) for the twelve months ending September 30, 2022 was -$207M, a 13.2% increase year-over-year.
Clovis Oncology, Inc. annual Operating Income (Loss) for 2021 was -$226M, a 25.3% increase from 2020.
Clovis Oncology, Inc. annual Operating Income (Loss) for 2020 was -$302M, a 19.8% increase from 2019.
Clovis Oncology, Inc. annual Operating Income (Loss) for 2019 was -$377M, a 12.9% decline from 2018.

Operating Income (Loss), Trailing 12 Months (USD)

Operating Income (Loss), Annual (USD)

Operating Income (Loss), YoY Annual Growth (%)

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
2021	-$226M	+$76.4M	+25.3%	Jan 1, 2021	Dec 31, 2021	10-K	2022-02-24
2020	-$302M	+$74.6M	+19.8%	Jan 1, 2020	Dec 31, 2020	10-K	2022-02-24
2019	-$377M	-$42.9M	-12.9%	Jan 1, 2019	Dec 31, 2019	10-K	2022-02-24
2018	-$334M	-$96.2M	-40.5%	Jan 1, 2018	Dec 31, 2018	10-K	2021-02-25
2017	-$238M	+$135M	+36.2%	Jan 1, 2017	Dec 31, 2017	10-K	2020-02-26
2016	-$373M	+$3.99M	+1.06%	Jan 1, 2016	Dec 31, 2016	10-K	2019-02-28
2015	-$377M	-$218M	-138%	Jan 1, 2015	Dec 31, 2015	10-K	2018-02-27
2014	-$158M	-$74.7M	-89.2%	Jan 1, 2014	Dec 31, 2014	10-K	2017-02-23
2013	-$83.8M	-$9.99M	-13.5%	Jan 1, 2013	Dec 31, 2013	10-K	2016-02-29
2012	-$73.8M	-$19.2M	-35.2%	Jan 1, 2012	Dec 31, 2012	10-K	2015-02-27
2011	-$54.6M	-$16M	-41.3%	Jan 1, 2011	Dec 31, 2011	10-K	2014-02-28
2010	-$38.6M			Jan 1, 2010	Dec 31, 2010	10-K	2013-03-14

Showing 1 to 12 of 12 entries

* An asterisk sign (*) next to the value indicates that the value is likely invalid.